Ki-67 cut-off of 50% predicts better survival outcomes in patients with mantle cell lymphoma (MCL): Pooled analysis from ALLIANCE/CALGB 50403 and MCL-RWS
   Google Scholar   
Citation:
Blood vol 41 (Supplement 1) 380
Meeting Instance:
ASH 2023
Year:
2023
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                                               
Networks:
CA043, IA018, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OH007, LAPS-UT003, LAPS-WI013, MN022, NC002, NY018, OH027   
Study
Alliance-A152021
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-50403
Phases:
N/A, 2
Keywords: